Related Experiment Video

Updated: Mar 22, 2026

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

2.5K

Disruption of Epac1 protects the heart from adenylyl cyclase type 5-mediated cardiac dysfunction

Wenqian Cai1, Takayuki Fujita1, Yuko Hidaka1

  • 1Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Biochemical and Biophysical Research Communications
|April 28, 2016
PubMed

Insights

The study reveals that Epac1 is crucial in type 5 adenylyl cyclase (AC5)-induced heart problems. Disrupting Epac1 in AC5 transgenic mice reduced cardiac dysfunction and atrial fibrillation susceptibility.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Type 5 adenylyl cyclase (AC5) is implicated in heart failure and arrhythmias.
  • Epac (exchange protein activated by cAMP) is a novel cAMP signaling mediator in the heart.
  • The role of Epac in AC5-mediated cardiac issues is not well understood.

Purpose of the Study:

  • To investigate the role of Epac1 in AC5-mediated cardiac dysfunction and arrhythmias.
  • To compare the phenotypes of AC5 transgenic mice with and without Epac1 disruption.

Main Methods:

  • Generated AC5 transgenic mice with selective Epac1 gene disruption (AC5TG-Epac1KO).
  • Administered chronic isoproterenol (ISO) infusion to AC5TG and AC5TG-Epac1KO mice.
  • Assessed cardiac function, susceptibility to atrial fibrillation (AF), cardiac apoptosis, and fibrosis.

Main Results:

  • AC5TG-Epac1KO mice showed significantly attenuated cardiac dysfunction and AF susceptibility compared to AC5TG mice after ISO infusion.
  • Cardiac apoptosis and fibrosis were also reduced in AC5TG-Epac1KO mice.
  • These results highlight Epac1's involvement in AC5's detrimental effects on the heart.

Conclusions:

  • Epac1 plays a significant role in AC5-mediated cardiac dysfunction.
  • Epac1 is a key mediator in the development of AC5-related atrial fibrillation susceptibility.
  • Targeting Epac1 may offer a therapeutic strategy for AC5-associated heart conditions.
Keywords:
Adenylyl cyclaseArrhythmiaCatecholamineEpacHeart failure

More Related Videos

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents10:53

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents

Published on: July 3, 2013

21.1K
In Vitro Culture of Epicardial Cells From Mouse Embryonic Heart06:31

In Vitro Culture of Epicardial Cells From Mouse Embryonic Heart

Published on: April 27, 2016

7.8K

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.2K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
6.8K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.8K
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
8.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643